Market Highlights

The food allergy diagnosis & treatment market is estimated to be valued at USD 18,083.2 million by 2023 and expected to grow at a CAGR of 3.14% during the forecast period. Among food source, the seafood segment accounted for the largest market share. However, milk food source segment has been projected to grow at the highest CAGR on account of increasing cases of lactose intolerance in Europe and North America.

In the diagnosis segment, secondary diagnosis steps such as Polymerase Chain Reaction (PCR), Enzyme-linked ImmunoSorbent Assay (ELISA), and others are expected to garner larger market share in comparison to primary diagnosis steps which includes skin prick test, blood test, food elimination diet test, and others. The major factor responsible for the market growth is the growing awareness regarding food-borne allergies and their expensive screening costs.

However, the only bottleneck in the growth trajectory of the global food allergy diagnosis and treatment market are the lack of skilled technical workforce and limitations associated with ELISA testing, such as false positive result, resulting in recurring cost.

Competitive landscapes

The key players in the market include SGS S.A. (Switzerland), Microbac Laboratories, Inc. (US), Intertek Group PLC (UK), AsureQuality Limited (New Zealand), TÜV SÜD AG (Singapore), Mérieux NutriSciences Corporation (US), Eurofins Scientific SE (Luxembourg) and ALS Limited (Australia).

All these major players in the food allergy and intolerance products market have been working vigorously to take themselves to a position where they can be proud of their work and aim to make the market reach the heights of success. Innovations in the market have been a major driving force in the growth of the market.



Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/food-allergy-diagnosis-treatment-market-7562



Market Segmentation:

Based on diagnosis, the global food allergy diagnosis & treatment market is segmented into primary and secondary. The primary segment includes—skin prick test, blood test, food elimination diet test, and others. This segment is expected to grow at a CAGR of 3.40% over the forecast period.

The secondary methods of food allergy diagnosis are included such as Polymerase Chain Reaction (PCR) methods, Enzyme-Linked Immunosorbent Assay (ELISA) method, and others. If food allergy detection fails through ELISA, PCR method is used to detect the allergen. PCR segment is projected to grow at a CAGR of 3.68% over the forecast period. ELISA is a sensitive method to test the presence of the antigen. This segment is estimated to grow at a CAGR of 2.57% over the forecast period.

On the basis of treatment, the global food allergy diagnosis & treatment market is segmented into antihistamines and adrenalin & corticosteroids. Antihistamines & corticoids segment is projected to grow at the highest CAGR of 3.42% over the forecast period while adrenalin segment is expected to grow at a CAGR of 3.39% over the forecast period.

By end-use, global food allergy diagnosis & treatment market has been segmented into hospitals & clinics, diagnostic centers, and research institutes. The hospital & clinics segment accounted for the larger market share of 71.5% in 2018. However, the diagnostic centers segment is projected to exhibit a higher CAGR of 3.47%.

Regional Analysis

Geographically, the global food allergy diagnosis & treatment market is segmented into Asia-Pacific, Europe, Americas, and the Middle East & Africa. As per MRFR analysis, Americas dominated the market, accounted for the largest share of the market in 2018, and expected to grow at a CAGR of 2.93%. Americas market is followed by Europe, which is accounting for the second largest number of shares in the global food allergy diagnosis & treatment market, as of 2018. Europe is estimated to reach USD 6,826.4 million by the end of 2023. Asia-Pacific is expected to have the largest market share during the forecast period and is also expected to grow with the highest CAGR of 4.56%, in 2018.

NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and wherever required we will be considering Covid19 Footprints for Better Analysis of Market and Industries. Cordially get in Touch for More Details